Topic: COVID-19 vaccine
China’s inhalable COVID-19 vaccine
Authorities in Shanghai have rolled out an inhalable vaccine against Covid-19 as a booster dose for previously vaccinated people. Who developed the inhalable COVID-19 vaccine? The Chinese biopharmaceutical...
Recommendation of Corbevax Jab for 5-12 years
The COVID-19 vaccines subject expert panel has given its recommendation for the emergency use of the Hyderabad-based Biological E’s Corbevax for children who are aged between 5 to...
First Plant-Derived COVID Vaccine
The first country in the world that has authorized the use of a plant-based COVID-19 vaccine is Canada. The two-dose vaccine of Medicago can be given to adults...
India- Panacea Biotec New COVID Vaccine
Government of India will partner with Coalition for Epidemic Preparedness Innovations (CEPI) and pharma company Panacea Biotec, for developing a new Covid Vaccine. Highlights They will develop vaccine candidates... Emergency Use Permission to Sputnik Light
The Drugs controller General of India recently granted Emergency Use Permission to Sputnik light COVID-19 vaccine. The expert panel of the central drug authority had recommended this. With...
African Union Summit
The 35th African Union summit was held at Addis Ababa in Ethiopia. Security and pandemic were given top priority at the summit. Key Points on the summit The... Bharat Biotech Nasal Booster Trials
The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are... Three – dose ZyCov – D to be launched in seven states
ZyCov – D is the second indigenous vaccine next to COVAXIN. The unique feature of ZyCov – D is that it is needle – less vaccine. At first,... ‘Knock every door’ campaign for Second-dose Vaccination
Union Health Ministry has asked states and Union Territories to come up with district-level plan and launch a “Har Ghar Dastak” (Knock every door) campaign across poor performing... India applies for vaccine loans from ADB & AIIB
India applied for a $2 billion loan from Asian Development Bank (ADB) and Asian Infrastructure Investment Bank (AIIB) to purchase about 700 million Covid-19 vaccines. Highlights India applied... WHO seeks clarifications from Bharat Biotech on Covaxin
According to World Health Organisation (WHO), additional clarifications from manufacturer are required to conduct final Emergency Use Listing (EUL) risk-benefit assessment for using Bharat Biotech’s Covaxin globally. Key...
